NCT00534001View on ClinicalTrials.gov

Bupropion in Helping Adults Stop Smoking

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

July 31, 2015

Conditions
Bladder CancerCervical CancerEsophageal CancerGastric CancerHead and Neck CancerKidney CancerLeukemiaLiver CancerLung CancerPancreatic CancerTobacco Use Disorder
Interventions
DRUG

bupropion hydrochloride

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00534001 - Bupropion in Helping Adults Stop Smoking | Biotech Hunter | Biotech Hunter